Senior Scientist in cancer therapeutics, San Diego | Former postdoc at MGH & HMS, Boston | PhD from Karolinska Institute, Sweden

San Diego, CA
Joined April 2018
CAR-T cell therapy can be great, but.. the T cells express PD1 and get exhausted. Check out this #GIF I made for a recent @jitcancer paper on this topic (bit.ly/35G8na3) ___ #cancer #immunotherapy #AcademicChatter #AcademicTwitter #scicomm (credit: @Biorender)
1
1
16
Just like people, T cells get exhausted. Taking a break helps! Here, the authors developed a SNIP CAR - “a protease-based platform for regulating CAR activity using an FDA-approved small molecule”, which showed diminished T cell exhaustion bit.ly/3LgUqUr #Immunotherapy
2
How can regulatory T cells (Tregs) be depleted in cancer? In this recent paper in @ScienceTM, the authors show how dual targeting of CTLA4 and CD47 on Tregs is effective. bit.ly/3yT5DWd #AcademicTwitter #Immunotherapy @UTSWNews
1
5
What’s happening with CAR-T cells and beyond in cancer? This nice review summarizes recent advances and efforts to leverage T cells and NK cells. nature.com/articles/s41423-0… #Immunotherapy #AcademicTwitter
4
11
Can pre-treatment with targeted therapy influence response to subsequent immunotherapy? Here, they show that "when tumors relapse after anti-MAPK targeted therapy, they are cross-resistant to immunotherapies". nature.com/articles/s43018-0… #Immunotherapy @NatureCancer
8
Can immunotherapy provide long-term responses? Median survival (months) for metastatic melanoma was reported at ASCO for: CTLA4 + PD1 👉 72.1 PD1 👉 36.9 CTLA4 👉 19.9 #AcademicTwitter #cancer #Immunotherapy @ASCOPost ascopost.com/news/june-2021/…
3
2
Predicting response to immunotherapy is important, but what’s a good marker? Here they show how TCR clonality of tumor-infiltrating T cells predict anti-PD1 efficacy: nature.com/articles/s41467-0… #AcademicTwitter #cancer #immunotherapy @NatureComms
1
6
Does tumor location/tissue site matter? Here they show how the same tumor cell line display different take rates, immune infiltration, and response to immunotherapy depending on where the tumor grows. cancerimmunolres.aacrjournal… #AcademicTwitter #cancer #Immunotherapy @CIR_AACR
How do tumor cells survive in the circulation? This recent paper highlights the importance of CCL5 as a mediator of immune evasion. nature.com/articles/s41467-0… #AcademicTwitter #cancer @NatureComms
3
20
When to give immunotherapy? Giving anti-CTLA4 BEFORE anti-PD1 was found to be superior in this recent paper: go.nature.com/3w43rZL #AcademicTwitter #Immunotherapy @NatImmunol @ljiresearch
1
1
1
2
Who will respond to immunotherapy? This recent paper suggests that the tumor microenvironment falls into 4 categories and can predict therapeutic response: bit.ly/3wQDcXR #AcademicTwitter @MDAndersonNews @BostonGeneCorp
1
18
43
Send a picture of something that shows very clearly you are a Grad/Undergrad student! This is mine 🤣 #phdchat @AcademicChatter @OpenAcademics @PhDVoice
25
7
1
92
Repurposing of drugs for cancer is already a popular strategy. Should all drugs, within reason, that have passed toxicity studies in any indication, be tested in preclinical models of cancer in a high-throughput manner? #AcademicTwitter
1
10
Just me having too much fun editing this video! Tell me more about you #phdchat #phdlife #postdoc #academictwitter
3
Patrik Andersson retweeted
Let me know if you have entered this graphical abstract contest at @BioRender - I would love to share yours❤️ #AcademicTwitter #phdchat #scicomm biorender.com/graphical-abst…
5
2
2
10
It really hits me hard seeing young people die in cancer. Moments of feeling hopeless is exchanged with motivation. Motivation to do better, to contribute to better therapies. What's your motivation? #AcademicTwitter #cancer #phdchat #beatcancer
2
1
10
Making friends with scorpions? 🦂 Enter this competition at @BioRender or just vote for my contribution 😃 #AcademicTwitter #sciencetwitter #phdchat #scicomm #cancer #Immunity #scicomm Link: app.biorender.com/contest/ga…
1
2
4